Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ngm Biopharmaceuticals Inc (NGM) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ngm Biopharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1426332.
Total stock buying since 2019: $362,455,416.
Total stock sales since 2019: $12,826,958.
Total stock option exercises since 2019: $1,614,476.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 1,664,298 | $8,122,866 | 85,082 | $438,342 | 85,082 | $122,518 |
| 2022 | 10,148,853 | $78,224,981 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 302,258 | $7,273,739 | 262,098 | $563,518 |
| 2020 | 5,718,504 | $78,557,600 | 227,327 | $4,460,080 | 170,515 | $790,271 |
| 2019 | 12,972,819 | $197,549,969 | 50,765 | $654,797 | 122,515 | $138,169 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-01 | 1,664,298 | $8,122,866 | 85,082 | $438,342 | 85,082 | $122,518 |
| 2022-12 | 1,200 | $5,972 | 0 | $0 | 0 | $0 |
| 2022-11 | 1,040,516 | $5,156,844 | 0 | $0 | 0 | $0 |
| 2022-10 | 885,280 | $3,768,858 | 0 | $0 | 0 | $0 |
| 2022-06 | 3,331,083 | $44,907,903 | 0 | $0 | 0 | $0 |
| 2022-05 | 2,341,671 | $24,385,404 | 0 | $0 | 0 | $0 |
| 2022-01 | 2,549,103 | $0 | 0 | $0 | 0 | $0 |
| 2021-12 | 0 | $0 | 30,000 | $552,150 | 87,098 | $239,818 |
| 2021-11 | 0 | $0 | 45,000 | $892,050 | 15,000 | $113,100 |
| 2021-10 | 0 | $0 | 32,000 | $652,250 | 2,000 | $24,120 |
| 2021-09 | 0 | $0 | 30,000 | $781,230 | 0 | $0 |
| 2021-08 | 0 | $0 | 40,258 | $959,934 | 8,000 | $96,480 |
| 2021-05 | 0 | $0 | 25,000 | $690,500 | 0 | $0 |
| 2021-04 | 0 | $0 | 25,000 | $616,250 | 0 | $0 |
| 2021-03 | 0 | $0 | 25,000 | $666,500 | 0 | $0 |
| 2021-02 | 0 | $0 | 25,000 | $718,750 | 0 | $0 |
| 2021-01 | 0 | $0 | 25,000 | $744,125 | 150,000 | $90,000 |
| 2020-12 | 0 | $0 | 25,000 | $705,575 | 0 | $0 |
| 2020-11 | 0 | $0 | 25,000 | $442,500 | 0 | $0 |
| 2020-10 | 0 | $0 | 25,000 | $425,500 | 0 | $0 |
| 2020-09 | 128,178 | $2,262,714 | 25,000 | $449,250 | 0 | $0 |
| 2020-08 | 290,504 | $5,162,182 | 25,000 | $475,500 | 0 | $0 |
| 2020-07 | 155,226 | $2,784,264 | 25,000 | $474,875 | 48,000 | $640,800 |
| 2020-06 | 0 | $0 | 25,000 | $536,750 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-31 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 176,730 | 5.00 | 883,473 |
| 2023-01-31 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 176,730 | 5.00 | 883,473 |
| 2023-01-31 | Column Group Ii Gp, Lp (10% Owner) | Buy | 176,730 | 5.00 | 883,473 |
| 2023-01-31 | Goeddel David V (Director) | Buy | 176,730 | 5.00 | 883,473 |
| 2023-01-30 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 7,542 | 5.00 | 37,710 |
| 2023-01-30 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 7,542 | 5.00 | 37,710 |
| 2023-01-30 | Column Group Ii Gp, Lp (10% Owner) | Buy | 7,542 | 5.00 | 37,710 |
| 2023-01-30 | Goeddel David V (Director) | Buy | 7,542 | 5.00 | 37,710 |
| 2023-01-17 | Chen Jin-long (Chief Scientific Officer) | Sale | 85,082 | 5.15 | 438,342 |
| 2023-01-17 | Chen Jin-long (Chief Scientific Officer) | Option Ex | 85,082 | 1.44 | 122,518 |
| 2023-01-11 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 209,000 | 4.76 | 994,840 |
| 2023-01-11 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 209,000 | 4.76 | 994,840 |
| 2023-01-11 | Goeddel David V (Director) | Buy | 209,000 | 4.76 | 994,840 |
| 2023-01-10 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 100,070 | 4.84 | 484,538 |
| 2023-01-10 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 100,070 | 4.84 | 484,538 |
| 2023-01-10 | Goeddel David V (Director) | Buy | 100,070 | 4.84 | 484,538 |
| 2022-12-12 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 300 | 4.98 | 1,493 |
| 2022-12-12 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 300 | 4.98 | 1,493 |
| 2022-12-12 | Column Group Ii Gp, Lp (Other) | Buy | 300 | 4.98 | 1,493 |
| 2022-12-12 | Goeddel David V (Director) | Buy | 300 | 4.98 | 1,493 |
| 2022-11-22 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 8,660 | 5.00 | 43,290 |
| 2022-11-22 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 8,660 | 5.00 | 43,290 |
| 2022-11-22 | Column Group Ii Gp, Lp (Other) | Buy | 8,660 | 5.00 | 43,290 |
| 2022-11-22 | Goeddel David V (Director) | Buy | 8,660 | 5.00 | 43,290 |
| 2022-11-21 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 71,994 | 5.00 | 359,898 |
| 2022-11-21 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 71,994 | 5.00 | 359,898 |
| 2022-11-21 | Column Group Ii Gp, Lp (Other) | Buy | 71,994 | 5.00 | 359,898 |
| 2022-11-21 | Goeddel David V (Director) | Buy | 71,994 | 5.00 | 359,898 |
| 2022-11-04 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 35,058 | 4.72 | 165,333 |
| 2022-11-04 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 35,058 | 4.72 | 165,333 |
| 2022-11-04 | Column Group Ii Gp, Lp (Other) | Buy | 35,058 | 4.72 | 165,333 |
| 2022-11-04 | Goeddel David V (Director) | Buy | 35,058 | 4.72 | 165,333 |
| 2022-11-03 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 104,090 | 4.99 | 519,096 |
| 2022-11-03 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 104,090 | 4.99 | 519,096 |
| 2022-11-03 | Column Group Ii Gp, Lp (Other) | Buy | 104,090 | 4.99 | 519,096 |
| 2022-11-03 | Goeddel David V (Director) | Buy | 104,090 | 4.99 | 519,096 |
| 2022-10-26 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 72,774 | 4.85 | 353,026 |
| 2022-10-26 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 72,774 | 4.85 | 353,026 |
| 2022-10-26 | Column Group Ii Gp, Lp (10% Owner) | Buy | 72,774 | 4.85 | 353,026 |
| 2022-10-26 | Goeddel David V (Director) | Buy | 72,774 | 4.85 | 353,026 |
| 2022-10-25 | Column Group Opportunity Iii Gp, Lp (10% Owner) | Buy | 51,046 | 4.75 | 242,366 |
| 2022-10-25 | Tcg Opportunity Iii Gp, Llc (10% Owner) | Buy | 51,046 | 4.75 | 242,366 |
| 2022-10-25 | Column Group Ii Gp, Lp (10% Owner) | Buy | 51,046 | 4.75 | 242,366 |
| 2022-10-25 | Goeddel David V (Director) | Buy | 51,046 | 4.75 | 242,366 |
| 2022-10-18 | Goeddel David V (Director) | Buy | 160,000 | 3.79 | 606,560 |
| 2022-10-17 | Goeddel David V (Director) | Buy | 100,000 | 3.18 | 318,300 |
| 2022-06-09 | Tcg Iv Gp, Llc (10% Owner) | Buy | 984,161 | 13.50 | 13,286,173 |
| 2022-06-09 | Column Group Ii Gp, Lp (Other) | Buy | 984,161 | 13.50 | 13,286,173 |
| 2022-06-09 | Goeddel David V (Director) | Buy | 984,161 | 13.50 | 13,286,173 |
| 2022-06-02 | Tcg Iv Gp, Llc (10% Owner) | Buy | 34,200 | 13.03 | 445,728 |
| 2022-06-02 | Column Group Ii Gp, Lp (10% Owner) | Buy | 34,200 | 13.03 | 445,728 |
| 2022-06-02 | Goeddel David V (Director) | Buy | 34,200 | 13.03 | 445,728 |
| 2022-06-01 | Tcg Iv Gp, Llc (10% Owner) | Buy | 92,000 | 13.45 | 1,237,400 |
| 2022-06-01 | Column Group Ii Gp, Lp (Other) | Buy | 92,000 | 13.45 | 1,237,400 |
| 2022-06-01 | Goeddel David V (Director) | Buy | 92,000 | 13.45 | 1,237,400 |
| 2022-05-31 | Tcg Iv Gp, Llc (10% Owner) | Buy | 61,806 | 13.47 | 832,279 |
| 2022-05-31 | Column Group Ii Gp, Lp (Other) | Buy | 61,806 | 13.47 | 832,279 |
| 2022-05-31 | Goeddel David V (Director) | Buy | 61,806 | 13.47 | 832,279 |
| 2022-05-27 | Tcg Iv Gp, Llc (10% Owner) | Buy | 2,710 | 13.45 | 36,452 |
| 2022-05-27 | Column Group Ii Gp, Lp (Other) | Buy | 2,710 | 13.45 | 36,452 |
| 2022-05-27 | Goeddel David V (Director) | Buy | 2,710 | 13.45 | 36,452 |
| 2022-05-26 | Tcg Iv Gp, Llc (10% Owner) | Buy | 20,201 | 13.49 | 272,592 |
| 2022-05-26 | Column Group Ii Gp, Lp (Other) | Buy | 20,201 | 13.49 | 272,592 |
| 2022-05-26 | Goeddel David V (Director) | Buy | 20,201 | 13.49 | 272,592 |
| 2022-05-25 | Tcg Iv Gp, Llc (10% Owner) | Buy | 43,292 | 13.44 | 581,628 |
| 2022-05-25 | Column Group Ii Gp, Lp (Other) | Buy | 43,292 | 13.44 | 581,628 |
| 2022-05-25 | Goeddel David V (Director) | Buy | 43,292 | 13.44 | 581,628 |
| 2022-05-24 | Tcg Iv Gp, Llc (10% Owner) | Buy | 17,828 | 13.37 | 238,324 |
| 2022-05-24 | Column Group Ii Gp, Lp (Other) | Buy | 17,828 | 13.37 | 238,324 |
| 2022-05-24 | Goeddel David V (Director) | Buy | 17,828 | 13.37 | 238,324 |
| 2022-05-20 | Tcg Iv Gp, Llc (10% Owner) | Buy | 19,034 | 13.48 | 256,540 |
| 2022-05-20 | Column Group Ii Gp, Lp (10% Owner) | Buy | 19,034 | 13.48 | 256,540 |
| 2022-05-20 | Goeddel David V (Director) | Buy | 19,034 | 13.48 | 256,540 |
| 2022-05-19 | Tcg Iv Gp, Llc (10% Owner) | Buy | 20,666 | 13.26 | 273,927 |
| 2022-05-19 | Column Group Ii Gp, Lp (10% Owner) | Buy | 20,666 | 13.26 | 273,927 |
| 2022-05-19 | Goeddel David V (Director) | Buy | 20,666 | 13.26 | 273,927 |
| 2022-05-18 | Tcg Iv Gp, Llc (10% Owner) | Buy | 62,650 | 13.20 | 827,230 |
| 2022-05-18 | Column Group Ii Gp, Lp (Other) | Buy | 62,650 | 13.20 | 827,230 |
| 2022-05-18 | Goeddel David V (Director) | Buy | 62,650 | 13.20 | 827,230 |
| 2022-05-17 | Tcg Iv Gp, Llc (10% Owner) | Buy | 89,049 | 13.42 | 1,194,770 |
| 2022-05-17 | Column Group Ii Gp, Lp (Other) | Buy | 89,049 | 13.42 | 1,194,770 |
| 2022-05-17 | Goeddel David V (Director) | Buy | 89,049 | 13.42 | 1,194,770 |
| 2022-05-16 | Tcg Iv Gp, Llc (10% Owner) | Buy | 33,166 | 12.90 | 427,907 |
| 2022-05-16 | Column Group Ii Gp, Lp (10% Owner) | Buy | 33,166 | 12.90 | 427,907 |
| 2022-05-16 | Goeddel David V (Director) | Buy | 33,166 | 12.90 | 427,907 |
| 2022-05-13 | Tcg Iv Gp, Llc (10% Owner) | Buy | 129,365 | .00 | 0 |
| 2022-05-13 | Column Group Ii Gp, Lp (10% Owner) | Buy | 129,365 | .00 | 0 |
| 2022-05-13 | Goeddel David V (Director) | Buy | 129,365 | .00 | 0 |
| 2022-05-12 | Tcg Iv Gp, Llc (10% Owner) | Buy | 83,175 | 11.71 | 974,228 |
| 2022-05-12 | Column Group Ii Gp, Lp (10% Owner) | Buy | 83,175 | 11.71 | 974,228 |
| 2022-05-12 | Goeddel David V (Director) | Buy | 83,175 | 11.71 | 974,228 |
| 2022-05-11 | Tcg Iv Gp, Llc (10% Owner) | Buy | 83,175 | 11.54 | 959,589 |
| 2022-05-11 | Column Group Ii Gp, Lp (10% Owner) | Buy | 83,175 | 11.54 | 959,589 |
| 2022-05-11 | Goeddel David V (Director) | Buy | 83,175 | 11.54 | 959,589 |
| 2022-05-10 | Tcg Iv Gp, Llc (10% Owner) | Buy | 31,265 | 11.36 | 355,295 |
| 2022-05-10 | Column Group Ii Gp, Lp (10% Owner) | Buy | 31,265 | 11.36 | 355,295 |
| 2022-05-10 | Goeddel David V (Director) | Buy | 31,265 | 11.36 | 355,295 |
| 2022-05-09 | Tcg Iv Gp, Llc (10% Owner) | Buy | 83,175 | 10.79 | 897,707 |
| 2022-05-09 | Column Group Ii Gp, Lp (10% Owner) | Buy | 83,175 | 10.79 | 897,707 |
| 2022-05-09 | Goeddel David V (Director) | Buy | 83,175 | 10.79 | 897,707 |
| 2022-01-25 | Tcg Iv Gp, Llc (10% Owner) | Buy | 599,701 | .00 | 0 |
| 2022-01-25 | Column Group Ii Gp, Lp (10% Owner) | Buy | 599,701 | .00 | 0 |
| 2022-01-25 | Goeddel David V (Director) | Buy | 599,701 | .00 | 0 |
| 2022-01-24 | Tcg Iv Gp, Llc (10% Owner) | Buy | 250,000 | .00 | 0 |
| 2022-01-24 | Column Group Ii Gp, Lp (10% Owner) | Buy | 250,000 | .00 | 0 |
| 2022-01-24 | Goeddel David V (Director) | Buy | 250,000 | .00 | 0 |
| 2021-12-29 | Woodhouse David J (Chief Executive Officer) | Option Ex | 17,654 | 7.92 | 139,819 |
| 2021-12-07 | Chen Jin-long (Chief Scientific Officer) | Sale | 15,000 | 18.60 | 279,000 |
| 2021-12-06 | Chen Jin-long (Chief Scientific Officer) | Sale | 15,000 | 18.21 | 273,150 |
| 2021-12-06 | Chen Jin-long (Chief Scientific Officer) | Option Ex | 69,444 | 1.44 | 99,999 |
| 2021-11-18 | Woodhouse David J (Chief Executive Officer) | Sale | 15,000 | 20.02 | 300,300 |
| 2021-11-18 | Woodhouse David J (Chief Executive Officer) | Option Ex | 15,000 | 7.54 | 113,100 |
| 2021-11-15 | Chen Jin-long (Chief Scientific Officer) | Sale | 30,000 | 19.73 | 591,750 |
| 2021-10-12 | Chen Jin-long (Chief Scientific Officer) | Sale | 15,000 | 20.14 | 302,100 |
| 2021-10-11 | Chen Jin-long (Chief Scientific Officer) | Sale | 15,000 | 20.41 | 306,150 |
| 2021-10-05 | Lieu Hsiao D (SVP, Chief Medical Officer) | Sale | 2,000 | 22.00 | 44,000 |
| 2021-10-05 | Lieu Hsiao D (SVP, Chief Medical Officer) | Option Ex | 2,000 | 12.06 | 24,120 |
| 2021-09-14 | Chen Jin-long (Chief Scientific Officer) | Sale | 15,000 | 25.84 | 387,525 |
| 2021-09-13 | Chen Jin-long (Chief Scientific Officer) | Sale | 15,000 | 26.25 | 393,705 |
| 2021-08-12 | Lieu Hsiao D (SVP, Chief Medical Officer) | Sale | 8,000 | 23.50 | 188,000 |
| 2021-08-12 | Lieu Hsiao D (SVP, Chief Medical Officer) | Option Ex | 8,000 | 12.06 | 96,480 |
| 2021-08-11 | Lieu Hsiao D (SVP, Chief Medical Officer) | Sale | 2,258 | 23.00 | 51,934 |
| 2021-08-10 | Chen Jin-long (Chief Scientific Officer) | Sale | 15,000 | 23.15 | 347,250 |
| 2021-08-09 | Chen Jin-long (Chief Scientific Officer) | Sale | 15,000 | 24.85 | 372,750 |
| 2021-05-03 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 27.62 | 690,500 |
| 2021-04-12 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 24.65 | 616,250 |
| 2021-03-01 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 26.66 | 666,500 |
| 2021-02-16 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 28.75 | 718,750 |
| 2021-01-05 | Chen Jin-long (Chief Scientific Officer) | Option Ex | 150,000 | .60 | 90,000 |
| 2021-01-04 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 29.77 | 744,125 |
| 2020-12-14 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 28.22 | 705,575 |
| 2020-11-02 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 17.70 | 442,500 |
| 2020-10-12 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 17.02 | 425,500 |
| 2020-09-02 | Kutzkey Tim (Other) | Buy | 27,595 | 17.67 | 487,603 |
| 2020-09-02 | Goeddel David V (Director) | Buy | 27,595 | 17.67 | 487,603 |
| 2020-09-01 | Chen Jin-long (Chief Scientific Officer) | Sale | 25,000 | 17.97 | 449,250 |
| 2020-09-01 | Kutzkey Tim (Other) | Buy | 36,494 | 17.64 | 643,754 |
| 2020-09-01 | Goeddel David V (Director) | Buy | 36,494 | 17.64 | 643,754 |
| 2020-08-28 | Kutzkey Tim (Other) | Buy | 26,135 | 17.89 | 467,555 |
| 2020-08-28 | Svennilson Peter (Other) | Buy | 26,135 | 17.89 | 467,555 |
| 2020-08-27 | Kutzkey Tim (Other) | Buy | 36,359 | 17.79 | 646,826 |
| 2020-08-27 | Svennilson Peter (Other) | Buy | 36,359 | 17.79 | 646,826 |
| 2020-08-25 | Kutzkey Tim (Other) | Buy | 100 | 18.00 | 1,800 |
| 2020-08-25 | Svennilson Peter (10% Owner) | Buy | 100 | 18.00 | 1,800 |
| 2020-08-24 | Kutzkey Tim (Other) | Buy | 11,024 | 17.96 | 197,991 |
| 2020-08-24 | Svennilson Peter (10% Owner) | Buy | 11,024 | 17.96 | 197,991 |
| 2020-08-21 | Kutzkey Tim (Other) | Buy | 7,321 | 17.97 | 131,558 |
| 2020-08-21 | Svennilson Peter (10% Owner) | Buy | 7,321 | 17.97 | 131,558 |
| 2020-08-17 | Kutzkey Tim (Other) | Buy | 6,425 | 17.89 | 114,943 |
| 2020-08-17 | Svennilson Peter (10% Owner) | Buy | 6,425 | 17.89 | 114,943 |
Insider trading activities including stock purchases, stock sales, and option exercises of NGM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ngm Biopharmaceuticals Inc (symbol NGM, CIK number 1426332) see the Securities and Exchange Commission (SEC) website.